FI862631A0 - Process for the preparation of a therapeutically useful membrane anchor active substance conjugate - Google Patents

Process for the preparation of a therapeutically useful membrane anchor active substance conjugate

Info

Publication number
FI862631A0
FI862631A0 FI862631A FI862631A FI862631A0 FI 862631 A0 FI862631 A0 FI 862631A0 FI 862631 A FI862631 A FI 862631A FI 862631 A FI862631 A FI 862631A FI 862631 A0 FI862631 A0 FI 862631A0
Authority
FI
Finland
Prior art keywords
active ingredient
preparation
active substance
therapeutically useful
membrane anchor
Prior art date
Application number
FI862631A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI862631A (en
FI94419C (en
FI94419B (en
Inventor
Guenther Jung
Karl-Heinz Wiesmueller
Joerg Metzger
Hans-Joerg Buehring
Gerhard Becker
Wolfgang Bessler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI862631A0 publication Critical patent/FI862631A0/en
Publication of FI862631A publication Critical patent/FI862631A/en
Application granted granted Critical
Publication of FI94419B publication Critical patent/FI94419B/en
Publication of FI94419C publication Critical patent/FI94419C/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Fodder In General (AREA)

Abstract

Conjugates are described in which the active ingredient is covalently bonded to the anchoring membrane, which is a compound of the formulae <IMAGE> in which A can be: sulphur, oxygen, disulphide (-S-S-), methylene (-CH2-) or -NH-; n = 0 to 5; m = 1 or 2; C* = an asymmetric carbon atom of R or S configuration, R, R' and R'' are identical or different and are an alkyl, alkenyl or alkynyl group having 7 to 25 carbon atoms or are hydrogen which can optionally be substituted by hydroxyl, amino, oxo, acyl, alkyl or cycloalkyl groups and R1 and R2 are identical or different and are defined as R, R' or R'' or can be -OR, -OCOR, -COOR, -NHCOR or -CONHR and X is an active ingredient or a spacer active ingredient group. The anchoring membrane active ingredient conjugates increase antibody formation.
FI862631A 1985-06-24 1986-06-19 Method for preparing a therapeutically useful membrane anchor-drug conjugate FI94419C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3522512 1985-06-24
DE3522512 1985-06-24
DE3546150 1985-12-27
DE19853546150 DE3546150A1 (en) 1985-06-24 1985-12-27 MEMBRANE ANCHOR ACTIVE CONJUGATE, ITS PRODUCTION AND USE

Publications (4)

Publication Number Publication Date
FI862631A0 true FI862631A0 (en) 1986-06-19
FI862631A FI862631A (en) 1986-12-25
FI94419B FI94419B (en) 1995-05-31
FI94419C FI94419C (en) 1995-09-11

Family

ID=25833375

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862631A FI94419C (en) 1985-06-24 1986-06-19 Method for preparing a therapeutically useful membrane anchor-drug conjugate

Country Status (12)

Country Link
EP (1) EP0210412B1 (en)
JP (1) JP2594259B2 (en)
KR (1) KR930008091B1 (en)
AT (1) ATE131491T1 (en)
AU (1) AU611385B2 (en)
CA (1) CA1340656C (en)
DE (2) DE3546150A1 (en)
DK (1) DK172399B1 (en)
ES (1) ES8801677A1 (en)
FI (1) FI94419C (en)
NO (1) NO174207C (en)
PT (1) PT82826B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3813821A1 (en) * 1988-04-22 1989-11-02 Hoechst Ag SYNTHETIC VACCINE AGAINST MOUTH AND CLAUS DISEASE AND METHOD FOR THEIR PRODUCTION
DE3937412A1 (en) * 1989-11-10 1991-05-16 Hoechst Ag SYNTHETIC VACCINE FOR THE SPECIFIC INDUCTION OF CYTOTOXIC T-LYMPHOZYTES
AU619443B2 (en) * 1986-04-21 1992-01-30 Bioenterprises Pty. Ltd. Immunopotentiation
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
JPS63107742A (en) * 1986-05-20 1988-05-12 Wako Pure Chem Ind Ltd Novel functional liposome and its preparation
DE3700173A1 (en) * 1987-01-05 1988-07-14 Hoechst Ag METHOD FOR PRODUCING LIPOPHILE AMINO ACID DERIVATIVES AND LIPOPHILE AMINO ACID DERIVATIVES
US5976839A (en) * 1987-03-13 1999-11-02 Bioenterprises Pty Limited Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides
DE59103985D1 (en) * 1990-05-30 1995-02-02 Deutsches Krebsforsch Polyethersubstituierte tumormittel.
DE4119856A1 (en) * 1991-06-17 1992-12-24 Hoechst Ag N-ACYL-S- (2-HYDROXYALKYL) -CYSTEINS, THE PRODUCTION AND USE THEREOF AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF SYNTHETIC IMMUNE ADJUVANTS AND SYNTHETIC VACCINANTS
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (en) * 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
DE4325317C2 (en) * 1993-07-29 1998-05-20 Univ Dresden Tech Process for the radioactive labeling of immunoglobulins
DE4329309A1 (en) * 1993-08-31 1995-03-09 Rapp Polymere Gmbh Lipopeptide compounds
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.
FR2727117A1 (en) * 1994-11-18 1996-05-24 Geffard Michel USE OF POLYLYSIN CONJUGATES FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES AND DEGENERATIVE DISORDERS OF AUTOIMMUN CHARACTER
US6117940A (en) * 1997-10-17 2000-09-12 Mjalli; Adnan M. M. Amino-ketone solid support templates
IL125908A (en) 1998-08-24 2005-05-17 Nst Neurosurvival Technologies Peptides and pharmaceutical compositions comprising same
IL131266A0 (en) 1999-08-05 2001-01-28 N S T Neurosurvival Technologi Peptides and pharmaceutical compositions comprising same
GB9915074D0 (en) * 1999-06-28 1999-08-25 Cortecs Plc Ligand-binding composition
DE102009034779A1 (en) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetic analogues of bacterial lipopeptides and their application for the therapy and prophylaxis of allergic diseases
EP2549990A1 (en) * 2010-03-23 2013-01-30 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
DE102011018499A1 (en) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topical nanoparticle vaccine for the immune stimulation of dendritic cells in the skin
US9701715B2 (en) * 2012-10-05 2017-07-11 The University Of Kansas Conformationally-constrained kinked endosomal-disrupting peptides
US10766928B2 (en) 2012-10-05 2020-09-08 The University Of Kansas Targeted conformationally-constrained kinked endosomal disrupting peptides
JP6458809B2 (en) 2014-04-25 2019-01-30 味の素株式会社 Immunostimulator
DE102016005550A1 (en) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvant for the induction of a cellular immune response
PE20211202A1 (en) 2017-08-24 2021-07-05 Novo Nordisk As COMPOSITIONS OF GLP-1 AND ITS USES
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860893D1 (en) * 1977-06-20 1981-11-05 Ciba Geigy Ag Lipopeptides, process for their preparation and pharmaceutical compositions containing them
US4125569A (en) 1977-08-25 1978-11-14 Mobil Oil Corporation Process for increasing hydrogenation rate of polymerized n-alphaolefins
EP0014815A3 (en) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptide derivatives, process for their preparation and intermediates, and pharmaceutical compositions containing one of these compounds
EP0114787B1 (en) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Peptide derivatives

Also Published As

Publication number Publication date
KR870000359A (en) 1987-02-18
DE3546150A1 (en) 1987-01-22
EP0210412B1 (en) 1995-12-13
NO862511D0 (en) 1986-06-23
CA1340656C (en) 1999-07-20
ES8801677A1 (en) 1988-02-16
EP0210412A3 (en) 1990-02-07
AU611385B2 (en) 1991-06-13
JP2594259B2 (en) 1997-03-26
KR930008091B1 (en) 1993-08-25
FI862631A (en) 1986-12-25
FI94419C (en) 1995-09-11
FI94419B (en) 1995-05-31
DK172399B1 (en) 1998-05-18
NO174207B (en) 1993-12-20
DE3650448D1 (en) 1996-01-25
NO174207C (en) 1994-03-30
NO862511L (en) 1986-12-29
PT82826B (en) 1989-01-17
DK294086D0 (en) 1986-06-23
DK294086A (en) 1986-12-25
ATE131491T1 (en) 1995-12-15
PT82826A (en) 1986-07-01
JPS6263600A (en) 1987-03-20
ES556417A0 (en) 1988-02-16
EP0210412A2 (en) 1987-02-04
AU5894386A (en) 1987-01-08

Similar Documents

Publication Publication Date Title
FI862631A0 (en) Process for the preparation of a therapeutically useful membrane anchor active substance conjugate
OA08182A (en) New peptide derivatives with a nitrogenous polycyclic structure, their method of preparation and the pharmaceutical compositions which contain them.
FI905575A0 (en) NY POLYPEPTIDFOERENING OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
DE3750906D1 (en) Chemically modified proteins and their production.
SE8305535D0 (en) PHARMACEUTICAL PREPARATION WITH ANTINICOTIC EFFECTS AND PROCEDURES FOR PREPARING THEREOF
FI893750A0 (en) The method produces a therapeutically active macrocyclic derivative
DE3650265D1 (en) Macrolide antibiotics and process for their preparation.
FR2649110B1 (en) NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
NO178923C (en) Analogous Process for Preparation of Therapeutically Active 24-Homo Vitamin D Derivatives
KR890014098A (en) Prophylaxis and treatment of central neurodegenerative diseases containing catechol amine derivatives
ES506284A0 (en) A PROCEDURE FOR THE PREPARATION OF ACIDS 1, CARBADESTIAPEN-2-EM-3-CARBOXILILOS 2- AND 6- SUBSTITUTED.
GB2192134A (en) Transdermal delivery of drugs
FR2660657B1 (en) NOVEL 3-AMINOCHROMANE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ATE27270T1 (en) THIOESTER OF ACETYLSALICYLIC ACID, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2040294T3 (en) NEW SULFUR COMPOUNDS, PROCEDURES FOR ITS PREPARATION, AS WELL AS MEDICINES.
SE8303913D0 (en) Heterocyclic Associations
PT84680A (en) PROCESS FOR THE PREPARATION OF 1,5-BENZOTHIAZEPINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2669030B1 (en) NEW IMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR910015301A (en) Treatment of Sleep Apnea
FR2639944B1 (en) NEW INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES8401966A1 (en) New cyanoguanidines, method for obtaining them and pharmaceutical compositions containing them.
ES2016931B3 (en) Procedure for the preparation of new aliphatic and cycloaliphatic amides of pyridylalkylamines or their N-oxide derivatives.
KR880007502A (en) Novel aminoalkanoyl-dibenzo [d, g] [1,3,6] dioxazosin and its preparation

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH

PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH

MA Patent expired